Sidney Hillman Health Center of Rochester et al v. Abbott Laboratories et al

  1. June 30, 2016

    RICO Claims Don't Hold Up In Abbott Off-Label Use Suit

    An Illinois federal judge held Wednesday that Racketeer Influenced and Corrupt Organizations Act claims over Abbott Laboratories' alleged off-label promotion of seizure drug Depakote fail because two health benefit plans didn't show a sufficiently direct link between the company's misrepresentations and their injuries.

  2. August 16, 2013

    Health Plans Sue Abbott Over Depakote Off-Label Scheme

    Abbott Laboratories Inc. was hit with a proposed class action in Illinois federal court Friday by three health benefit plans alleging it unfairly reaped hundreds of millions of dollars from third-party payors through off-label marketing and kickbacks for prescriptions of anti-seizure medication Depakote.